Multiple Sclerosis News Today Forums › Forums › Trials and Research › FDA Approves Generic Version of Aubagio to Treat Relapsing MS, Glenmark Pharma Announces

  • Trials and Research

    FDA Approves Generic Version of Aubagio to Treat Relapsing MS, Glenmark Pharma Announces

    Posted by MS News Today Moderator on November 27, 2018 at 8:12 am

    A generic version of Aubagio — teriflunomide tablets marketed by Glenmark Pharmaceuticals — is being approved in the US at 7 mg and 14 mg doses. Click here to read more about this story.

    If your insurance plans only cover generic medications, this could help lower your costs. Is this good news for you?

    replied 5 years, 5 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .